Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
about
The impact of new technologies on vaccine development.Production of specific antibodies against protein A fusion proteinsAn antibody to a synthetic peptide that recognises SV40 small-t antigen.Toward hepatitis B vaccinesThe recognition of proteins and peptides by antibodies.Prediction of sequential antigenic regions in proteins.Current approaches to vaccine preparation.Mapping epitopes and antigenicity by site-directed maskingImmunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera.Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.Cross-reactive and strain-specific antipeptide antibodies to Pseudomonas aeruginosa PAK and PAO pili.Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidisImmunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.Crystal structures of pheasant and guinea fowl egg-white lysozymesSuccessful immunization with a totally synthetic diphtheria vaccineAntiviral response elicited by a completely synthetic antigen with built-in adjuvanticity.Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitroIsolation of antibodies specific to sickle hemoglobin by affinity chromatography using a synthetic peptide.Detection in vivo of a new gene product (gene III) of cauliflower mosaic virus.Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.The conformational restriction of synthetic vaccines for malaria.A static accessibility model of protein antigenicity.Covalent bond or noncovalent bond: a supramolecular strategy for the construction of chemically synthesized vaccines.Perspectives on antigenicity and idiotypy.Adjuvant effect of a peptidoglycan attached covalently to a synthetic antigen provoking anti-phage antibodies.A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virusCharacterization of antibodies to chicken riboflavin carrier protein. Immunoneutralizing ability of antibodies to a sequence-specific region of the proteinProbing into the realm of proteins and immunity.Effect of antigenic structure on antibody biosynthesis.Synthetic Antigens and Vaccines
P2860
Q30411839-35333440-EAA7-44B7-B80C-446A66DF834DQ33880423-12951046-A474-4240-83D5-E0EE923420B4Q33927959-8718AB8A-FE7C-4F58-A2D5-DADEA4EA8947Q33982711-6D7C3628-DE7F-44E0-9B46-2F4B32D5AD10Q33993576-08BC81C1-0ED9-4DDC-9A6E-A7377D2B45E5Q34377036-D3A482EF-DBB4-4097-A2B2-DA088F002A10Q34688016-E5DC30ED-4026-4335-BE8F-D7C1C63B39DCQ34694924-CE6434F6-6CDF-41C8-B00D-1502DB7986DDQ35006519-3E0817D0-AC32-4F7C-B141-8FD61757C31BQ35044513-4E7AD4C3-068C-4980-8F59-697D55771D50Q35102987-835FD3A9-6857-49D1-9715-C7481359BD1AQ35436549-C8E479AD-192C-4F1A-B59C-E3B925E3BF58Q36257657-B8062F2F-A4A0-425E-9359-89F5FA6AFACFQ36278544-88FB621D-97BB-4370-967F-F63182D5EF4EQ36308543-E43F82DC-3C51-4412-A6CF-777854CB252BQ36416339-3ACCF25E-C198-4DC4-8F19-8B55506BCB09Q36432500-DEFFCE16-A82E-417A-8B27-261081C4C276Q36924207-62E38556-66A5-4DF6-982A-6A6E7327F0F0Q37463175-DBC6A08B-11A8-41D6-973C-06CB72E4DFF6Q37574722-DD1DA590-D16B-47F0-A19C-549404725A7CQ37580591-E70FD220-E5FA-44A7-AB58-9B2E27210ABAQ37690884-15ECAF55-FC85-4CAA-9C91-AA18443D2825Q37800088-E8ACE76E-31F2-4867-9882-25DC949D2270Q38213356-54BFC1F0-15E6-43CE-873F-9F5633675730Q38962995-D4A0E6F3-EBED-43FD-9E86-1DB77B8695BAQ39612160-36D00EE4-0C84-461F-8D60-82C123DC169DQ39628409-BC3F6B41-82EF-44E3-933C-2B45F0EC620FQ39878888-C38F3017-0A2D-4B3B-B6D4-ED13C32B414EQ39880328-45602ECD-800B-40EE-8FF5-E3FFA1A861D5Q42816978-009E2252-2959-4EAE-AE06-34DAB33BDDBDQ42846579-9CA775B8-E264-499A-A174-A7EA4EB45505Q53692544-80A456B2-013F-4DEC-8193-A6EA23AC1896Q58352976-AB9C6DF3-F1EB-41B7-8C16-DCE0AC09F247
P2860
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1971
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
@en
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
@nl
type
label
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
@en
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
@nl
prefLabel
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
@en
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
@nl
P2093
P2860
P356
P1476
Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.
@en
P2093
P2860
P304
P356
10.1073/PNAS.68.7.1450
P407
P577
1971-07-01T00:00:00Z